Page 4 - Advm News Today : Breaking News, Live Updates & Top Stories | Vimarsana

BML Capital Management LLC bought a new stake in Adverum Biotechnologies, Inc. (NASDAQ:ADVM – Get Rating) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 7,067,179 shares of the biotechnology company’s stock, valued at approximately $4,095,000. Adverum Biotechnologies comprises about 3.9% of […]

StockNews.com upgraded shares of Adverum Biotechnologies (NASDAQ:ADVM – Get Rating) from a sell rating to a hold rating in a research report released on Saturday morning. Separately, LADENBURG THALM/SH SH started coverage on shares of Adverum Biotechnologies in a report on Tuesday, March 7th. They issued a buy rating and a $2.00 target price on […]

StockNews.com upgraded shares of Adverum Biotechnologies (NASDAQ:ADVM – Get Rating) from a sell rating to a hold rating in a research report report published on Saturday. Separately, LADENBURG THALM/SH SH began coverage on shares of Adverum Biotechnologies in a report on Tuesday, March 7th. They set a buy rating and a $2.00 target price for […]

StockNews.com lowered shares of Adverum Biotechnologies (NASDAQ:ADVM – Get Rating) from a hold rating to a sell rating in a research report released on Friday morning. Separately, LADENBURG THALM/SH SH assumed coverage on shares of Adverum Biotechnologies in a report on Tuesday, March 7th. They set a buy rating and a $2.00 price objective on […]

Shares of Adverum Biotechnologies, Inc. (NASDAQ:ADVM – Get Rating) crossed above its 50 day moving average during trading on Tuesday . The stock has a 50 day moving average of $0.74 and traded as high as $0.91. Adverum Biotechnologies shares last traded at $0.91, with a volume of 295,073 shares trading hands. Wall Street Analyst […]